Fig. 2

A FE–SEM of DOX–CIS-Nio@PEG–FA, B TEM of DOX–CIS-Nio@PEG–FA, C FT-IR spectra of different components used for the formation of niosomal formulation, a: span60, b: Cholesterol, c: Niosome, d: DOX, e: CIS, f: DOX-Nio, g: CIS-Nio, h: DOX + CIS-Nio, i: DOX–CIS-Nio@PEG–FA, j: DSPE–PEG2000–PEG–FA, D XRD patterns of different samples, a: Niosome, b: DOX, c: CIS, d: DOX-Nio, e: CIS-Nio, f: DOX–CIS-Nio, g: DOX–CIS-Nio@PEG–FA, E Differential Scanning Calorimetry (DSC), a: DOX-Nio, b: DOX, c: Niosome, d: CIS-Nio, e: DOX + CIS-Nio, f: DOX–CIS-Nio@PEG–FA, F DLS, G In vitro release of CIS, a: free CIS, b: CIS-Nio, c: CIS + DOX-Nio, d: DOX–CIS-Nio@PEG–FA, H In vitro release of DOX a: free DOX, b: DOX-Nio, c: DOX + CIS-Nio, and d: DOX–CIS-Nio@PEG–FA